Drug development investors
14 investors that name Drug development among their sectors are recorded here: 9 venture capital firms, 2 corporate venture arms, 2 venture studios and 1 investor. Stated investment stages run from pre-seed to growth. Most are headquartered in the United States (3), Switzerland (1) and Czechia (1). Every fact comes from the investor’s own website and links back to the page it was read from. Coverage is incomplete and biased toward investors who publish clearly.
| Investor | Layer | Type | Stage | Headquarters |
|---|---|---|---|---|
| Aditum Bio biotech · drug development · therapeutics |
Direct investor | Venture capital | Not stated | |
| Aglaia Management B.V. oncology · drug development · life sciences |
Direct investor | Venture capital | Seed | Bilthoven, Netherlands |
| AION Labs AI · pharma · drug discovery · drug development |
Direct investor | Venture studio | Pre-seed | Rehovot, Israel |
| Astellas Venture Management biotechnology · therapeutics · platform technologies · drug discovery |
Direct investor | Corporate venture | Seed – Series A | South San Francisco, United States |
| AurorA-TT biotech · drug development · therapeutics |
Direct investor | Other | Pre-seed – Seed | Milan, Italy |
| Flerie Invest biotech · pharmaceutical · drug development · related devices |
Direct + LP | Venture capital | Pre-seed – Growth | Stockholm, Sweden |
| i&i Prague drug development · diagnostics · medical technologies · life sciences |
Direct investor | Venture studio | Pre-seed – Seed | Prague, Czechia |
| Longevity Funds 2 LLC longevity · biotech · drug development |
Direct investor | Venture capital | Seed – Series C+ | San Francisco, United States |
| MPM BioImpact biotechnology · drug development · oncology · immunology |
Direct investor | Venture capital | Seed – Growth | Boston, United States |
| Novartis Venture Fund biotechnology · biopharmaceuticals · life sciences · healthcare |
Direct investor | Corporate venture | Seed – Growth | Basel, Switzerland |
| Parkinson's Pioneer Capital Advisors Ltd life sciences · biotech · neurology · drug development |
Direct investor | Venture capital | Seed – Series B | |
| Rhea Venture Partners life sciences · drug development · therapies · technologies |
Direct investor | Venture capital | Seed – Growth | Greece |
| Vesalius Biocapital IV Partners SàRL drug development · medical devices & diagnostics · eHealth / mHealth · Biopharma |
Direct investor | Venture capital | Seed – Growth | Contern, Luxembourg |
| 鑽石生技投資(股)公司 biotech · drug development · medtech |
Direct investor | Venture capital | Not stated | Taipei, Taiwan |